Specialization
Hematology/internal medicine
Focus of research
- Pathogenesis and (immuno)therapy of B cell malignancies.
-
Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis
Hengeveld, P. J., Veelken, H., van Bergen, C. A. M., Quinten, E., Vervoordeldonk, M. Y. L., Ismailzada, W., Barendse, R. S., Dubois, J. M. N., van Oers, M. H. J., Geisler, C. H., Kater, A. P., Westerweel, P. E., Langerak, A. W. & Levin, M-D., Sept 2023, In: Leukemia. 37, 9, p. 1929-1932 4 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
Eichhorst, B., Niemann, C. U., Kater, A. P., Furstenau, M., von Tresckow, J., Zhang, C., Robrecht, S., Gregor, M., Juliusson, G., Thornton, P., Staber, P. B., Tadmor, T., Lindstrom, V., da Cunha-Bang, C., Schneider, C., Poulsen, C. B., Illmer, T., Schottker, B., Nosslinger, T., Janssens, A., & 30 others, 2023, In: New England journal of medicine. 388, 19, p. 1739-1754 16 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Prof. Anton Hagenbeek 1948-2021: Father of MRD and Lymphoma Expert
Löwenberg, B., Kersten, M. J., Gale, R. P. & van Oers, M., 1 Sept 2021, In: Leukemia. 35, 9, p. 2725-2726 2 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications